Cannabis–Alcohol Substitution Findings Did Not Establish a Universal Treatment Benefit
A review described evidence consistent with substitution in some settings alongside worse alcohol-treatment outcomes associated with cannabis use in others. Those findings do not support a universal claim that one substance reliably replaces the other beneficially.
The reviewed populations and time points differed
Yurasek and colleagues discuss elevated alcohol craving or consumption during cannabis abstinence in some people with alcohol use disorder. They also summarize studies linking cannabis use during alcohol treatment with fewer later alcohol-abstinent days.
These observations concern different situations. A short-term change during cessation and a longer-term treatment outcome are not interchangeable measures of substitution.
Direction of association remained uncertain
A person may change use because symptoms, circumstances or treatment changed. Observational relationships cannot automatically establish which substance caused the change in the other.
The review also describes exceptions to a uniform negative association. Combining selected results into a single causal story would erase that heterogeneity.
A substitution strategy needs direct evaluation
A clinical claim requires evidence about relevant benefits and harms, not merely an inverse association between reported use amounts. Reduced use of one substance does not establish improved overall functioning.
The review’s contribution is identifying mixed patterns and a need for better longitudinal and intervention evidence. It does not establish a cannabis treatment protocol for alcohol use disorder or predict an individual’s course.
Related: Interpreting cannabis tolerance claims.
Research cited
Yurasek AM; Aston ER; Metrik J Current addiction reports · 2017 · 4(2):184 PMID 32670740 · DOI 10.1007/s40429-017-0149-8. Co-use of Alcohol and Cannabis: A Review..
